SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 20.67-0.3%Dec 13 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patlawche11 who wrote (45901)4/25/2018 2:32:02 PM
From: patlawche113 Recommendations

Recommended By
dorightbythem
drtom1234
erippetoe

  Read Replies (1) of 53464
 
FWIW...IMMU132 status changed today from active, recruiting to active, not recruiting for Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers. So...I would imagine they are currently not treating new/additional patients for UC, as well as for other indications in this trial.

clinicaltrials.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext